Marc Bonten, University Medical Center Utrecht, The Netherlands
Marc Bonten (born 16-10-1964) got his MD (1991) and PhD (“the role of colonization of the upper intestinal tract in the pathogenesis of ventilator-associated pneumonia, 1994) at the Maastricht University Medical School, the Netherlands. He registered as internist in 2000, as infectious disease specialist in 2002 and as clinical microbiologist in 2008, all at the University Medical Center Utrecht, the Netherlands. Since August 2008 he is head of the department Medical Microbiology and leading the research group of infectious Disease Epidemiology of the Julius Center of Health Sciences and Primary Care, both at the UMC Utrecht, where he is professor of molecular epidemiology of infectious diseases since 2002. Since July 2015 he is also appointed as scientific advisor for Antimicrobial Resistance at the National Institute of Health and the Environment and the Center for Infectious Disease Control, in the Netherlands.
He serves as the chair the Infection & Immunity Focus Programme of the UMC Utrecht, served on the editorial board of Intensive Care Medicine (2008-2012), and served on several Scientific Advisory Boards (JPI-AMR, SWAB). He is a VICI laureate (2006) from the Dutch Science Association, PI of the CAPiTA study (investigator-initiated study funded by Wyeth, later Pfizer), coordinator of the EU-funded project R-GNOSIS and scientific coordinator of the IMI-funded consortiums COMBACTE-NET, COMBACTE-CARE, COMBACTE-MAGNET and COMBACTE-CDI. In May 2015 he received the Excellence Award of the European Society of Clinical Microbiology and Infectious Diseases.